HomeEDIT • NASDAQ
add
Editas Medicine Inc
Previous close
$1.34
Day range
$1.23 - $1.34
Year range
$1.17 - $11.58
Market cap
104.01M USD
Avg Volume
3.16M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 61.00K | -98.86% |
Operating expense | 18.09M | 20.69% |
Net income | -62.14M | -38.03% |
Net profit margin | -101.87K | -11,974.54% |
Earnings per share | -0.75 | -36.36% |
EBITDA | -64.07M | -31.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 265.09M | -24.18% |
Total assets | 327.57M | -35.09% |
Total liabilities | 151.93M | 5.37% |
Total equity | 175.63M | — |
Shares outstanding | 82.55M | — |
Price to book | 0.63 | — |
Return on assets | -46.09% | — |
Return on capital | -67.72% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -62.14M | -38.03% |
Cash from operations | -52.59M | -48.31% |
Cash from investing | 83.98M | 181.68% |
Cash from financing | 0.00 | — |
Net change in cash | 31.39M | 122.70% |
Free cash flow | -36.53M | -77.39% |
About
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
Founded
Nov 2013
Website
Employees
265
